Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.16
-0.02 (-0.24%)
At close: Aug 8, 2025, 5:30 PM CET
Smartsheet Market Cap
Svas Biosana has a market cap or net worth of €43.57 million as of August 13, 2025. Its market cap has decreased by -0.35% in one year.
Market Cap
43.57M
Enterprise Value
72.16M
Revenue
122.29M
Ranking
n/a
PE Ratio
7.44
Stock Price
$8.16
Market Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 43.57M, a decrease of -46.30%. That is a compound annual growth rate of -15.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 43.68M | 13.96% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.37B |
| DiaSorin | 4.49B |
| Amplifon | 3.35B |
| EL.En. | 951.41M |
| Philogen | 867.14M |
| Safilo Group | 534.37M |
| GPI S.p.A. | 480.71M |
| Pharmanutra | 453.27M |